Classification of (cancer) cachexia: Any improvements to expect?
|
|
- Elisabeth Price
- 6 years ago
- Views:
Transcription
1 6 th Research Congress of EAPC Glasgow, June 11th 2010 Session Cachexia of EPCRC and EAPC RN Classification of (cancer) cachexia: Any improvements to expect? The joint work of many persons involved, thank you! Ken Fearon, Stefan Anker, Ingvar Bosaeus, Eduardo Bruera, Robin Fainsinger, Aminah Jatoi, Charles Loprinzi, Neil MacDonald, Giovanni Mantovani, Mellar Davis, Maurizio Muscaritoli, Faith Ottery, Lukas Radbruch, Paula Ravasco, Declan Walsh, Andrew Wilcock, Stein Kaasa, Vickie Baracos, Paddy Stone, David Blum, Tora Skeidsvoll, Ben Tan, Marianne Hjermstad, Susanne Linder, Rolf Oberholzer, and many others PD Florian Strasser, MD ABHPM Head, Oncological Palliative Medicine Oncology; Dept. Internal Medicine & Palliative Care Center, Cantonal Hospital St.Gallen, Switzerland
2 My patients Who has cachexia? All: detect cachexia Prioritize and diagnose cachexia Goal-directed inteventions Drugs. cachexia. cancer Nutrition Physical Psychosocial Effectiveness
3 Ed1 Definitions ACS Old Definition of Cancer Cachexia Weight # * (involuntay, 2% 2 Mts or 5% 6 Mts) Appetite # (VAS >=3/10 or a Problem ) Oral Intake # * (<20 kcal/kg or <75% normal) # Anorexia/Cachexia Loprinzi C et al., early 90-ies * Malnutrition Kondrup J et al. Clin Nutr 2003;22:415-21
4 Ed1 Definitions ACS Why is an improvement needed? 1/3 Ask Eduardo Late referrals: too late to improve cachexia Uncertainty about fatigue patients: cachexia?. Physical, cognitive, emotional fatigue 1. Multidimensional causes of fatigue 2 1: Strasser F, Müller-Käser I, Dietrich D. J Pain Symptom Manage 2009;38(4): : Strasser F. Curr Opin Clin Nutr Metab Care 2008;11(4):417-21
5 Ed1 Definitions ACS Why is an improvement needed? 2/3 Anti-cachexia drugs: Progestins, C-steroids high price for short-term better appetite 1 Anti-cancer treatment variable cachexia improvement & deterioration 2 Nutrition: supplement, enteral, parenteral very variable results from nutrition studies 3 ESPEN guidelines leave many questions open 4 Physical function interventions responses seem to vary, not explained: age, sex 5 Psychosocial interventions uncertainty when and how to counsel 6 1: Oxford Textbook of Palliative Medicine, 4 th Edition; 2: Oberholzer R et. al., EAPC 2010, Poster #281; 3: Ravasco P et al., Clin Nutr 2007;26:7-15; 4: Bozzetti F et al. Clinical Nutrition 28 (2009) ; 5: Oldervoll L et al. EAPC 2010, oral comm. #30; 6: Hopkinson J et al., EAPC 2010, oral comm. #106
6 Ed1 Definitions ACS Why is an improvement needed? 3/3 Patient Population in Clinical trials high attrition rate 1,2,et.al. promising drugs (phase I/II) were not effective 1 mechanism-based treatment (α-tnf) in unselected patients (trial negative) 3 substantial improvement in placebo controls: variability of basic cachexia management 1,2,et.al Endpoints in clinical trials endpoint not reflecting key mechanism of action (anabolic agent, endpoint appetite) 4 too many co-factors (weight: obese, fluids) 1: Fearon KC et al. J Clin Oncol 2006;24:3401-7; 2: Strasser F et al. J Clin Oncol 2006;24: : Jatoi A, et al. Cancer 2007;110: ; 4: Loprinzi C et al. J Clin Oncol. 1999;17:
7 The solution now?
8 Process with Systematic Literature Reviews, formal delphi consensus processes, pilot validation SLR Secondary SLR Impact of tumor control SLR Psychosocial consequences NEW Consensual Cancer Cachexia Classification. Definition and Diagnosis. Phases (early, cachexia, refractory). Phenotypes (inflamm, anorexia, muscle)
9 New Cancer Cachexia definition ,2 international accepted 3 Cancer cachexia is a multifactorial syndrome defined by a ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Its pathophysiology is characterized by negative protein and negative energy balance driven by a variable combination of reduced food intake and abnormal metabolism. 1: Blum D et al. (EPCRC) Support Care Cancer 2010;18(3): : Fearon K & Strasser F, et al., (EPCRC) submitted : Argilés JM et al. J Am Med Dir Assoc 2010;11:229-30
10 New Cancer Cachexia definition 2010 Cancer cachexia is a multifactorial syndrome defined by a ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Its pathophysiology is characterized by negative protein and negative energy balance driven by a variable combination of reduced food intake and abnormal metabolism. IMPROVEMENT: Diagnose both patients who have cachexia with poor appetite or good appetite but substantial catabolism Example: Literature Review: 1 Of patients with >10% WL, 39% had no anorexia and 16% had normal food intake, while 12% of patients having anorexia had no WL 2 1: Blum D et. al., submitted 2:Sarhill N et al. Support Care Cancer 2003;11:652-9.
11 New Cancer Cachexia definition 2010 Cancer cachexia is a multifactorial syndrome defined by a ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Its pathophysiology is characterized by negative protein and negative energy balance driven by a variable combination of reduced food intake and abnormal metabolism. IMPROVEMENT: To assess, treat, and evaluate patients with cachexia, no longer is fatigue (alone) used, but now (objective) physical function. 1 1: Helbostad JL et al. Supp care Cancer 2010
12 New Cancer Cachexia definition 2010 Cancer cachexia is a multifactorial syndrome defined by a ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Its pathophysiology is characterized by negative protein and negative energy balance driven by a variable combination of reduced food intake and abnormal metabolism. Diagnosis of cancer cachexia: In the absence of simple starvation, cancer cachexia syndrome is diagnosed by [ ] IMPROVEMENT: clear requirement to diagnose and treat secondary nutrition-impact symptoms 1,2 1: Kubrak C et al. Head Neck Jul 22. 2: Omlin AG & Strasser F. J Clin Oncol, 2007; 25 (Proceedings):9058
13 Comprehensive Nutritional Counselling improves survival WHY? Updated data from ESMO Symposium Nutrition and Cancer Zürich
14 Intervention for patients with treatment-related Secondary Nutrition-Impact Symptoms 1 ( simple Starvation )
15 New Diagnosis of Cancer Cachexia 2010 In the absence of simple starvation, cancer cachexia syndrome is diagnosed by involuntary weight loss >5% over the last 6 months. Weight loss should be ongoing during the last 1 2 months. In patients with significant fluid retention, large tumor mass or obesity (BMI >30kg/m2) significant muscle wasting may occur without weight loss. A direct measure of muscularity is recommended. Any cancer patient with involuntary weight loss who develops a BMI < 20 kg/m 2.
16 Old Cancer Cachexia diagnosis Definitions of weight loss in papers included in the systematic literature review on cancer cachexia: 1 5% [n=12 papers], 10% [n=20], specific percentages [n=29], or absolute quantity lost in kilograms (n=10) compared with either pre-illness weight [n=33] or during a recent time period (6 months [n=18], 3 months [n=4], or not specified [n=16]). IMPROVEMENT: Common international Diagnostic Criteria to describe (comparable) patient populations 1: Blum D et. al., submitted
17 New Classification of Cancer Cachexia 2010: Pre-cachexia Cachexia Phases Late (irreversible) cachexia al Normal - Pre-cachexia Weight loss 5% Metabolic/endocrine change Weight loss > 5% Often reduced food Intake/Systemic Inflammation Cachexia cachexia Severe muscle wasting Low performance score Immunocompromised <3 months expected survival Refractory Death Weight loss 5% Anorexia Metabolic change Often r Weight loss >5% or BMI<20 & WL >2% reduced food Intake/Systemic Inflammation Cancer disease: pro- catabolic and not responsive to anticancer treatment. Low performance score. <3 months expected survival
18 Classification of Cancer Cachexia: Phases Pre-clinical cachexia (or early cachexia) In patients with cancer, early clinical (e.g., loss of appetite, decreased nutritional intake) and metabolic (e.g. insulin resistance, inflammation), signs of cachexia can be present, without the presence of significant involuntary weight loss (i.e. 5%) IMPROVEMENT: Defined (?) clinical entity for innovative clinical trial design (early intervention) The Multidimensional Cancer Cachexia Intervention Trial (MENACE) of EAPC-RN/PRC
19 Classification of Cancer Cachexia: Phases Refractory (late) cancer cachexia Advanced muscle wasting (with or without loss of fat) due to progressive cancer, not anymore responding to anticancer treatment. Patients have a low performance status and short life expectancy (<3months). It is evident that the burden of artificial nutritional support would outweigh any potential benefit. Therapeutic interventions focus typically on alleviating the consequences/complications of cachexia, e.g. symptom control (appetite stimulation, nausea), eating-related distress of patients and families.
20 Classification of Cancer Cachexia: Phases Refractory (late) cancer cachexia Advanced muscle wasting (with or without loss of fat) due to progressive cancer, not anymore responding to anticancer treatment. Patients have a low performance status and short life expectancy (<3months). It is evident that the burden of artificial nutritional support would outweigh any potential benefit. Therapeutic interventions focus typically on allevi-ating the consequences/complications of cachexia, e.g. symptom control (appetite stimulation, nausea), eating-related distress of patients and families. IMPROVEMENT: Defined (?) clinical entity for intervention studies: patients symptoms, and psychosocial distress, as well as family member A new EORTC-refractory cachexia module reflecting patients experiences is planned Psychosocial intervention studies
21 Classification of Cancer Cachexia: Domains Anorexia/ food intake (central, chemosensory, gut) Catabolic drive (Tumor, Inflammation) Decreased muscle mass and strength IMPROVEMENT: Definition Phenotype for genetic studies Option for mechanism-based clinical trials Lenalidomid cachexia study: for inflammatory cachexia Anti-IL-6 antibody trial, u.a.
22 Lenalidomide for in inflammatory cancer cachexia: randomized, 3-arm (CRP-guided vs fixed dose) placebo-controlled proof-of-concept study Aim: To investigate the safety and efficacy of lenalidomide in patients with advanced solid tumors having inflammatory cancer cachexia on the background of basic cachexia management (treatment of secondary anorexia, nutritional support, physical activity, symptom control) Protocol coordinator: Susanne Linder, RN; Rolf Oberholzer, MD PI: Florian Strasser, St.Gallen, Switzerland Protocol supported by Clinical Trials Unit, St.Gallen Swiss Group for Clinical Cancer Research labeled study Sponsor Cantonal Hospital St.Gallen. Free Drug & Support by Celgene
23 IMPROVEMENT: New generation of clinical trials in cancer cachexia awaited - Common, international Definition - Common, international Diagnosis - Key domains, mechanism-based - Phases: pre-cachexia, cachexia, refractory - Assessments: (more) relevant for endpoints Population: define Phase define basic management (combinations) presence of target mechanism
24 IMPROVEMENT: new endpoints in Cancer Cachexia Clinical trials awaited old Endpoints Appetite stimulation subjective Symptom Nutritional intake estimation by patient invalid Body weight invalid if obesity, fluid retention Quality of life to broad concept new Endpoints Nutritional intake requires measurement Muscle mass by DEXA or CT/MRI Muscle strenght intrapatient change Physical functionactivity checklists (ADL + ) 6-min-walk, body-worn-sensors
25 Improvements for daily clinical care?
26 Cancer Cachexia Classification for Clinical Use SIPP Cancer Cachexia Assessment Tool Storage Intake Potential Weight loss: compared to usual weight, duration, fluid retention/obesity Anorexia, early satiety, chemosensory % normal intake, 1-2 day dietary record, Secondary nutrition-impact symptoms Tumor [catabolic] activity, Prognosis C-reactive protein Performance Physical functioning, muscle strenght Psychosocial consequences From SIPP: classify cachexia (phase, phenotype) multidimensional interventions
27 Are IMPROVEMENTS awaited for clinical care? Validation of the SIPP tool needed Cancer Cachexia-SIPP-Validation Study Prospective, multicenter study, applying SIPP together with basic cachexia management recommendations, assess definition of phases by investigators and characterisation of responders (goal-achievement) to multimodal interventions. Modular approach with EPCS. Writing Committee Proposal: Blum D, Strasser F, Fearon K, Baracos V, Fainsinger R Kaasa S, et al.
28 Conclusions The new (cancer) cachexia classification has the potential to improve Clinical care by allowing. definition of cachexia phases, namely refractory cachexia. define phenotype-, and phase-directed multidimensional interventions Clinical research by. Better and common definition of patients. Improved classification-based endpoints Further validation work is needed (model ECS-CP)
29 Thank you! Contact
30
31 Simple Starvation: Secondary Nutrition-Impact Symptoms Nausea Vomiting Constipation Diarrhea Defecation after meal Pain Dyspnoea Fatigue Anxiety/depression Sense of hopelessness Stomatitis Dysgeusia Dental problems Difficulty chewing Dysosmia Xerostomia Thick saliva Dysphagia Epigastric pain Abdominal pain Practical Implications: SCREEN SEARCH for S-NIS & Treat
32 Secondary nutrition impact symptoms Chemosensory Dysfunction Hutton J et al. J Pain Symptom Manage 2007; 33:156-65
33 Secondary nutrition impact symptoms Xerostomia N=75 head and neck cancer patients >6 mts after radiotherapy, cured Dirix P et al. Supp Care Cancer 2008;16:171-9
34 Simple starvation - secondary nutrition impact symptoms: few evidence for impact on oral intake Master search "cancer-cachexia" citations 1893 abstracts Systematic Literature Review snow-balling (ongoing) 264 papers hand-search (ongoing) 43 papers in systematic review publication 3 Papers: O-NI & Secondary - Ravasco P et al. Head & Neck Macqueen CE et al. J Hum Nutr Dietet Hutton JL et al. J Pain Symptom Manage papers: oral nutritional intake correlated with secondary causes 11 papers: weight loss correlated with secondary causes 4 papers: qualitative papers 25 papers: descriptive papers, supporting the hypothesis Omlin A et al. EAPC 2008, Poster #11
35 Multidisciplinary Cancer Cachexia Clinic 1 (nurse, nutritionist, psycho-oncologist, palliative cancer care MD) 58 pts (age 65 years [38, 85]; 28 female / 30 male) Cancer types: 24 GI, 13 GU, 12 lung/ent, 9 other Survival 151 days [7, 776]) 6.9% weight loss (-6, 22; 21%<2%), 21 kg/m2 BMI (15, 26), 52 mg/dl CRP (1, 272; 32% normal), 5.6 anorexia VAS (10: bad) First visit: 68% of Nutritional Intake needs 1466 kcal [400, 2700], 47g protein [15, 108] Follow-up visit (21 days; 13, 64): 15/19 pts increased kcal (400kcal), 15/16 protein (32g) Palliative Cancer Care can improve nutritional intake and often stabilises body weight 1: Blum D, Omlin A et al. Comprehensive cancer cachexia staging and its impact in the outpatient oncology setting: A phase II study. J Clin Oncol Ann Meeting ASCO 2009.
Cancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland
Cancer cachexia: assessment and classification KCH Fearon University of Edinburgh Scotland 1 What is the cancer cachexia phenotype?...the shoulders, clavicles, chest and thighs melt away. This illness
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Nutritional consequences of cancer therapy Continued nutritional support and monitoring in cancer F. Strasser (Switzerland) ESPEN 2008 Saturday, 13 th September 2008 14:30
More informationIngvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden
Cachexia in Cancer Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden Severe, progressive malnutrition and wasting often is seen in advanced cancer, with weight loss long associated
More informationNutrition support for sarcopenia in cancer patients
Nutrition support for sarcopenia in cancer patients Kalliopi Anna Poulia, RD, MMedSci, PhD Clinical Nutritionist-Dietitian, Laiko General Hospital of Athens Vice President of the Hellenic Dietetic Association
More informationNutritional care during and after chemo- and radiotherapy. M. Larsson (SE)
ESPEN Congress Leipzig 2013 Nursing Session Nutritional care during and after chemo- and radiotherapy M. Larsson (SE) Nutritional care during and after chemo- and radiotherapy Maria Larsson, RN, PhD Nurse
More informationNutritional requirements in advanced cancer patients
Nutritional requirements in advanced cancer patients Paula Ravasco p.ravasco@fmedicina.ulisboa.pt Laboratory of Nutrition Faculty of Medicine of the University of Lisbon Medical School of Lisbon Portugal
More informationA new era of therapeutics for cancer cachexia. Cachexia is a continuum with 3 stages of clinical relevance
A new era of therapeutics for cancer cachexia I. Depletion of Reserves II. Limitation of food intake III. Catabolic Drivers IV. Impact and outcomes Vickie Baracos PhD Professor and Alberta Cancer Foundation
More informationDiet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford
Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet and cancer Diet and cancer Nutrition research Lack of funding RCTs Low quality Small sample sizes
More informationMetabolic issues in nutrition: Implications for daily care
Metabolic issues in nutrition: Implications for daily care Ingvar Bosaeus Dept of Clinical Nutrition Sahlgrenska University Hospital Göteborg, Sweden Nutritional problems in cancer In western countries,
More informationnutrition and cancer Weight loss and Quality of Life (QoL) Nutrition and QoL wound healing Surgery & RT hospital stay rehospitalisations Malabsorption
The impact of nutrition intervention in cancer patients Paula Ravasco Unidade de Nutrição e Metabolismo Instituto de Medicina Molecular Faculdade de Medicina da Universidade de Lisboa deterioration is
More informationCANCER CACHEXIA. Barry J A Laird Clinician Scientist in Palliative Medicine, University of Edinburgh & European Palliative Care Research Centre
CANCER CACHEXIA Barry J A Laird Clinician Scientist in Palliative Medicine, University of Edinburgh & European Palliative Care Research Centre Consultant in Palliative Medicine BWoSCC and Edinburgh Cancer
More informationDefinition and classification of cancer cachexia: an international consensus
Definition and classification of cancer cachexia: an international consensus Kenneth Fearon*, Florian Strasser*, Stefan D Anker, Ingvar Bosaeus, Eduardo Bruera, Robin L Fainsinger, Aminah Jatoi, Charles
More informationNutritional Counselling, cancer Outcome and Quality of Life!
Nutritional Counselling, cancer Outcome and Quality of Life! Paula Ravasco p.ravasco@fm.ul.pt Unit of Nutrition and Metabolism, Institute of Molecular Medicine Faculty of Medicine of the University of
More informationESPEN guidelines: Nutritional interventions in advanced cancer care. -An overview and pending research questions
1 ESPEN guidelines: Nutritional interventions in advanced cancer care -An overview and pending research questions Tora Skeidsvoll Solheim, MD, PhD Oslo, October 2017 2 3 Definition of cachexia Cancer cachexia
More informationHorizon Scanning Centre November Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer first line
Horizon Scanning Centre November 2012 Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer first line SUMMARY NIHR HSC ID: 5206 This briefing is based on information available
More informationESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK)
ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Multimodal therapy of cancer cachexia K. Fearon (UK) Multimodal therapy for cancer cachexia KCH Fearon Learning objectives Understand
More informationESPEN Congress Leipzig 2013
ESPEN Congress Leipzig 2013 Nutrition and cancer: impact on outcome Survival, quality of life, reduced toxicity: what can be achieved in cancer patients? M.A.E. van Bokhorst - de van der Schueren (NL)
More informationClinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia
Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia Stéphane M. Schneider, MD, PhD, FEBGH Professor of Nutrition and ESPEN ECPC Chair In proto-indo-european, Latin and Greek Under
More informationThe use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust
The use of omega-3 fatty acids in the management of cancer cachexia Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust Overview Cancer cachexia Clinical features Pathogenesis
More informationLearning objectives. What is nutritional care? NUTRITIONAL ISSUES IN CANCER
NUTRITIONAL ISSUES IN CANCER Jane Hopkinson PhD, RGN Macmillan Post Doctoral Fellow Faculty of Health Sciences, University of Southampton, UK 1 Learning objectives q To understand contributory factors
More informationNeoplastic Disease KNH 406
Neoplastic Disease KNH 406 Cancer Carcinogenesis - Etiology Genes may be affected by antioxidants, soy, protein, fat, kcal, alcohol Nutritional genomics study of genetic variations that cause different
More informationSingle Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell lung cancer
Single Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell Response to consultee and commentator comments on the draft remit and draft scope (pre-referral)
More informationMultimodal cachexia management
Multimodal cachexia management Dr Martin Chasen MBChB FCP(SA) MPhil(Pall Care) Medical Oncologist/Director of Palliative care William Osler Health Services Toronto CANADA Do you have anything that you
More informationProgramme overview (subject to change)
Programme overview (subject to change) Time 0800-0900 Premiminary programme - Thursday 7 June Olavshallen 1204 seats Olav Tryggvasson 325 seats Haraldsalen 140 seats Tavern/ Brattøra 210 seats 0900-1100
More informationO ρόλος της διατροφής κατά τη θεραπεία του καρκίνου
O ρόλος της διατροφής κατά τη θεραπεία του καρκίνου I. Gioulbasanis MD, PhD Dept. of Chemotherapy Larissa General Clinic E. Patsidis INTRODUCTION Καρκινογένεση Ενεργός Νόσος Επιβιώσαντες με καρκίνο (cancer
More informationThe Challenge of Cancer Cachexia
The Challenge of Cancer Cachexia Jeffrey Crawford, MD George Barth Geller Professor for Research in Cancer Co-Director, Solid Tumor Therapeutics Program Duke Cancer Institute Disclosures Advisory Board/Consultant:
More informationAlterazioni metaboliche e nutrizionali in corso di artrite reumatoide e malattie autoimmuni Alessio Molfino, MD, PhD
Alterazioni metaboliche e nutrizionali in corso di artrite reumatoide e malattie autoimmuni Alessio Molfino, MD, PhD Direttore: Prof. Filippo Rossi Fanelli alessio.molfino@uniroma1.it Rheumatoid arthritis
More informationANAMORELIN FOR CACHEXIA. Series 20 CASE REPORT FORM
1 ANAMORELIN FOR CACHEXIA Series 20 CASE REPORT FORM Palliative Care Clinical Studies Collaborative (PaCCSC) RAPID Pharmacovigilance in Palliative Care The case report form (CRF) is to be completed in
More informationPredic've/prognos'c value of anorexia-cachexia
Predic've/prognos'c value of anorexia-cachexia Prognos'c value of Anorexia-Cachexia Rela%onship between Prognosis Weight Appe%te Nutri%onal Impact Symptoms Body Composi%on Mul%ple Domains of cachexia uncertainty
More informationInaugural Guildford Supportive Care in Cancer Course
Inaugural Guildford Supportive Care in Cancer Course SUPPORTIVE CARE OVERVIEW Declan Walsh 4 th November 2015 A BRIEF HISTORY OF MEDICINE 2000 BC HERE, EAT THIS ROOT 1000 AD THAT ROOT IS HEATHEN, SAY THIS
More informationESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Mechanisms and clinical features of cachexia P.
ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Mechanisms and clinical features of cachexia P. Ravasco (PT) Mechanisms and clinical features of nutritional patterns in cancer
More informationFriday Poster Discussion. Heather Wakelee, MD Stanford University Stanford Cancer Institute
Friday Poster Discussion Heather Wakelee, MD Stanford University Stanford Cancer Institute Posters DR. STEINER- PREVALENCE AND IMPACT OF HYPOGONADISM IN CANCER PATIENTS WITH MUSCLE WASTING IN A PHASE IIB
More informationDr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC)
1 Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC) 2 Acknowledgements Prof Marie Fallon (group lead EPAS) University
More informationPsychosocial Consequences of Cancer Cachexia: The Development of an Item Bank
Vol. 46 No. 6 December 2013 Journal of Pain and Symptom Management 795 Original Article Psychosocial Consequences of Cancer Cachexia: The Development of an Item Bank Hanspeter H ane, MD, Rolf Oberholzer,
More informationThe cancer anorexia-cachexia syndrome: myth or reality?
Support Care Cancer (2010) 18:265 272 DOI 10.1007/s00520-009-0772-6 SHORT COMMUNICATION The cancer anorexia-cachexia syndrome: myth or reality? Wael Lasheen & Declan Walsh Received: 23 July 2009 / Accepted:
More informationHealth Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017
Health Related Quality of Life: Cancer cachexia Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017 Overview to lecture Introduction/Scotland Patient related outcome measures
More informationMedical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria Hospital MONTREAL
Eating Drinking, Living after Curative Therapy for Esophageal cancer Dr. Martin Chasen Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria
More informationNutrition to improve patients outcomes
Nutrition to improve patients outcomes Dietary Counselling: a Simple but Effective way to improve Cancer Outcomes Paula Ravasco p.ravasco@fm.ul.pt Unit of Nutrition and Metabolism, Institute of Molecular
More informationUnderstanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research
Published online in Wiley Online Library (wileyonlinelibrary.com) REVIEW Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research Christine
More informationMalnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationESPEN Congress Copenhagen 2016
ESPEN Congress Copenhagen 2016 PARENTERAL NUTRITION IN ONCOLOGY PATIENTS INDICATIONS AND CONTRAINDICATIONS F. Bozzetti (IT) Parenteral nutrition in oncology patients indications and contraindications Federico
More informationChanges in Dietary Intake, Body Weight, Nutritional Status, and Metabolic Rate in a Pancreatic Cancer Patient
Case Report Clin Nutr Res 2013;2:154-158 pissn 2287-3732 eissn 2287-3740 Changes in Dietary Intake, Body Weight, Nutritional Status, and Metabolic Rate in a Pancreatic Cancer Patient So Young Kim 1, Gyung
More informationSession 1 Clinical Manifestations of Cancer Cachexia (Chair: Aminah Jatoi, MD)
Cancer Cachexia: Molecular Mechanisms and Therapeutic Approaches Boston, September 21-23, 2012 Friday, September 21, 2012 1:00 pm Registration and Poster Set-up Foyer Maverick A&B 4:00-4:10 pm Introductory
More informationRenal cachexia. Professor Joanne Reid
Renal cachexia Professor Joanne Reid Cachexia Cachexia is a complex metabolic syndrome associated with underlying illness and characterised by muscle loss, with or without loss of fat Definition of cachexia
More informationNutrition Update: Anorexia and Cachexia
Nutrition Update: Anorexia and Cachexia Kristen Kreamer, AOCNP, APRN-BC, CRNP, MSN Barbara Rogers, CRNP, AOCN, APN-BC, MN Fox Chase Cancer Center Nutrition Update: Anorexia and Cachexia LEARNING OBJECTIVES:
More informationNutrition Update: Anorexia and Cachexia
Nutrition Update: Anorexia and Cachexia Kristen Kreamer, AOCNP, APRN-BC, CRNP, MS Fox Chase Cancer Center Faculty Biography Kristen Kreamer, AOCNP, APRN-BC, CRNP, MSN is Nurse Practitioner, Ambulatory
More information* P< 0.01 for each comparison; P< for all groups combined. ! During anticancer therapy, involuntary weight loss is
COMMON Head and Neck Esophagus Stomach Pancreas Lung INTERMEDIATE Colorectal Ovarian Lymphoma UNCOMMON Breast Prostate Leukemia M Schattner, MSKCC, ASPEN 2008 Retrospective review of QOL (EORTC QLQ C-30)
More informationABC of palliative care: Anorexia, cachexia, and nutrition
BMJ 1997;315:1219-1222 (8 November) Clinical review ABC of palliative care: Anorexia, cachexia, and nutrition Eduardo Bruera Top Does the patient have... Why is the patient... Cachexia is a complex syndrome
More informationTo see a description of the Academy Recommendation Rating Scheme (Strong, Fair, Weak, Consensus, Insufficient Evidence) visit the EAL.
WWW.ANDEAL.ORG HEART FAILURE HF: EXECUTIVE SUMMARY OF RECOMMENDATIONS (2017) Executive Summary of Recommendations Below are the major recommendations and ratings for the Academy of Nutrition and Dietetics
More informationPancreatic cancer Palliative Care
Pancreatic cancer Palliative Care Snežana Bošnjak Institute for Oncology and Radiology of Serbia Dept. Supportive Oncology & Pall Care Serbia, Belgrade Pancreatic Cancer: Palliative Care Abdominal / epigastric
More informationBrief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia
Support Care Cancer (2015) 23:1355 1364 DOI 10.1007/s00520-014-2484-9 ORIGINAL ARTICLE Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia John
More informationY A L E S C H O O L O F M E D I C I N E. This is a CME accredited activity. The presenters and there are no conflicts of interest.
This is a CME accredited activity. The presenters and there are no conflicts of interest. Pain in Pancreatic Cancer More than 50% of patients with pancreatic cancer suffer from abdominal and back pain
More informationNutrition. Chapter 45. Reada Almashagba
Nutrition Chapter 45 1 Nutrition: - Nutrient are organic substances found in food and are required for body function - No one food provide all essential nutrient Major function of nutrition: providing
More informationNutritional Support in Cancer Topic 26
Nutritional Support in Cancer Topic 26 Module 26.3 Multimodal Therapy for Cancer Cachexia Kenneth Fearon, MD, FRCS(Glas), FRCS(Ed), FRCS(Eng), Professor of Surgical Oncology, Clinical Surgery, University
More informationUpdates on the Role of Nutrition Support in Cancer. Todd Canada, PharmD, BCNSP, FASHP University of Texas MD Anderson Cancer Center Houston, Texas
Updates on the Role of Nutrition Support in Cancer Todd Canada, PharmD, BCNSP, FASHP University of Texas MD Anderson Cancer Center Houston, Texas Learning Objectives After this presentation, attendees
More informationIntegrating Palliative and Oncology Care in Patients with Advanced Cancer
Integrating Palliative and Oncology Care in Patients with Advanced Cancer Jennifer Temel, MD Massachusetts General Hospital Cancer Center Director, Cancer Outcomes Research Overview 1. Why should we be
More informationHOMES AND SENIORS SERVICES. APPROVAL DATE: February 2011 REVISION DATE: July 2018
Page 1 of 7 POLICY: Each resident s level of nutrition and hydration risk will be identified by the Registered Dietitian during the RAI-MDS Admission Assessment and thereafter during the quarterly, significant
More informationNutritional assessment & support for the upper GI cancer patient
Nutritional assessment & support for the upper GI cancer patient Catherine Fleuret Specialist Dietitian, The Royal Marsden Outline Nutritional status & implications The role of nutrition & the dietitian
More informationMolecular Mechanisms associated with the Cancer-Cachexia Syndrome
Molecular Mechanisms associated with the Cancer-Cachexia Syndrome Prof. Dr. Josep M. Argilés Department of Biochemistry & Molecular Biology University of Barcelona, Spain Disclosures: DANONE (Scientific
More informationNutrition for Patients with Cancer or HIV/AIDS Chapter 22
Nutrition for Patients with Cancer or HIV/AIDS Chapter 22 Nutrition for Patients with Cancer or HIV/AIDS Cancer and HIV/AIDS can cause devastating weight loss and malnutrition. Nutrition therapy Cannot
More informationNutrition for Cancer. Nutrition for Cancer. Patients. Geoffrey Axiak. Clinical Nutrition Nurse Mater Dei Hospital
Nutrition for Cancer Nutrition for Cancer Patients Geoffrey Axiak Clinical Nutrition Nurse Mater Dei Hospital Change in Energy Expenditure in Change in Energy Expenditure in Disease (Northwestern University
More informationCancer Cachexia. Current and Future Management Options
Cancer Cachexia Current and Future Management Options Cancer Cachexia Overview Symptoms Pathophysiology Current Treatment Options New Drugs Cancer Cachexia Overview " the shoulders, clavicles, chest and
More informationImproving documentation and coding of malnutrition a five year journey
Improving documentation and coding of malnutrition a five year journey Natalie Simmance, Chief Dietitian Clara Newsome Sally Bell Sonia Grundy St Vincent's Hospital Melbourne Patient Malnutrition common
More informationCachexia and Nutri/on SG. Egidio Del Fabbro Virginia Commonwealth University Richmond,VA,USA
Cachexia and Nutri/on SG Egidio Del Fabbro Virginia Commonwealth University Richmond,VA,USA egidio.delfabbro@vcuhealth.org Defini/on of Cancer Cachexia MulO-factorial syndrome Characterized by ongoing
More informationImpact of a multidisciplinary rehabilitation nutrition team on evaluating sarcopenia, cachexia and practice of rehabilitation nutrition
140 ORIGINAL Impact of a multidisciplinary rehabilitation nutrition team on evaluating sarcopenia, cachexia and practice of rehabilitation nutrition Yoji Kokura, RD 1 ; Hidetaka Wakabayashi, MD, PhD 2
More informationTHE UNIVERSITY of EDINBURGH
THE UNIVERSITY of EDINBURGH Professor Kenneth Fearon MB ChB(Hons), MD, FRCPS (Glasgow), FRCS (Edinburgh), FRCS (England) Memorial Cancer Cachexia Symposium Royal Society of Edinburgh, George Street, Edinburgh
More informationAttitude and pratice regarding diagnosis and treatment of starvation, cachexia and sarcopenia Roundtable ESDN Older Adult
Attitude and pratice regarding diagnosis and treatment of starvation, cachexia and sarcopenia Roundtable ESDN Older Adult Elisabet Rothenberg Ass Prof, President of DRF, Sweden Lies ter Beek PhD Student,
More informationMultimodality therapy for esophageal cancer: should nutritional support be included? Federico Bozzetti. ESMO SYMPOSIUM Zurich March 2009
Multimodality therapy for esophageal cancer: should nutritional support be included? Federico Bozzetti ESMO SYMPOSIUM Zurich 20-21 March 2009 TOPICS Nutritional status: obesity and weight loss (WL) Metabolic
More informationAge related changes in food intake, weight and body composition. Keerti Sharma, MD AGSF
Age related changes in food intake, weight and body composition Keerti Sharma, MD AGSF Objectives Understand age related changes in appetite and food intake Discuss age related changes in weight and body
More informationCombination therapy in cachexia
Review Article Combination therapy in cachexia Egidio Del Fabbro Virginia Commonwealth University, Richmond, VA, USA Correspondence to: Egidio Del Fabbro, MD. Virginia Commonwealth University, 1101 E Marshall
More informationNUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS
NUTRITIONAL OPTIMIZATION IN PRE LIVER TRANSPLANT PATIENTS ACHIEVING NUTRITIONAL ADEQUACY Dr N MURUGAN Consultant Hepatologist Apollo Hospitals Chennai NUTRITION IN LIVER FAILURE extent of problem and consequences
More informationMALNUTRITION RISK AND SARCOPENIA HEAD AND NECK CANCER
1 MALNUTRITION RISK AND SARCOPENIA HEAD AND NECK CANCER Mary E. Platek PhD, RD Adjunct Assistant Professor of Oncology Roswell Park Cancer Institute Associate Professor Department of Dietetics D Youville
More informationSteps towards an international classification system for cancer pain
1 EPCRC Steps towards an international classification system for cancer pain Stein Kaasa Ghent, 18 October, 2012 Cancer Clinic St. Olavs University Hospital, Trondheim, Norway Background 2 Pain Background:
More informationNutritional assessment in clinical practice. What to measure?
Nutritional assessment in clinical practice. What to measure? Nicolette Wierdsma PhD RD Dietitian VU University medical center, specialized in gastroenterology diseases and nutritional diagnostics and
More informationLa Nutrizione Artificiale dall ospedale al domicilio
La Nutrizione Artificiale dall ospedale al domicilio Federico Bozzetti Cagliari 25-26 Marzo 2009 Nutrition of the cancer patient Prevalence of malnutrition Effect of malnutrition on the outcome: - survival
More information1st Abbott International Conference for Cancer Nutrition Therapy. Proceedings Booklet
1st Abbott International Conference for Cancer Nutrition Therapy Proceedings Booklet The 1st Abbott International Conference for Cancer Nutrition Therapy April 12-14, 2010 The 1st Abbott International
More informationNutritional support in multimodal therapy for cancer cachexia
Support Care Cancer (2008) 16:447 451 DOI 10.1007/s00520-007-0388-7 REVIEW ARTICLE Nutritional support in multimodal therapy for cancer cachexia Ingvar Bosaeus Received: 27 June 2007 / Accepted: 5 December
More informationCancer Pain Assessment and Classification
Cancer Pain Assessment and Classification Peter Lawlor Elisabeth Bruyère & University of Ottawa 4/06/2012 EAPC Preconf Plenary 1 Goals of systematic cancer pain assessment and classification Clinical care
More informationCANCER CACHEXIA. Negativity cancer nutrition. Do we think it s s important? Lack of past success alimentation trials counselling therapeutic failures
CANCER CACHEXIA A wasting syndrome characterized by loss of muscle and fat caused by an aberrant host response to a wide variety of chronic illnesses. Anorexia usually accompanies cachexia,, and is caused
More informationNutrition. By Dr. Ali Saleh 2/27/2014 1
Nutrition By Dr. Ali Saleh 2/27/2014 1 Nutrition Functions of nutrients: Providing energy for body processes and movement. Providing structural material for body tissues. Regulating body processes. 2/27/2014
More informationPREOPERATIVE WEIGHT LOSS AS A PREDICTOR OF LONG-TERM SUCCESS FOLLOWING BARIATRIC SURGERY
ESPEN Congress Gothenburg 2011 Educational Session - Dietetic session PREOPERATIVE WEIGHT LOSS AS A PREDICTOR OF LONG-TERM SUCCESS FOLLOWING BARIATRIC SURGERY Alejandra Parri Bonet EDUCATIONAL SESSION
More informationThe correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia
JBUON 2015; 20(1): 325-331 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE The correlation between a chronic inflammatory marker Tartrate-Resistant
More informationMonitoring of nutritional status in hospitalized patients: the Australian experience (OP008)
ESPEN Congress Barcelona 2012 Dietetic session Monitoring of nutritional status in hospitalized patients: the Australian experience (OP008) E. Agarwal (Australia) The Australasian Nutrition Care Day Survey:
More informationNutritional concerns of overweight / obese older persons. Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University
Nutritional concerns of overweight / obese older persons Gordon L Jensen, MD, PhD Dept Nutritional Sciences Penn State University Prevalence of obesity among older adults: NHANES 1999-2004 Sex Age (years)
More informationArtificial nutrition and rehabilitation for head and neck cancer patients in the community setting
Artificial nutrition and rehabilitation for head and neck cancer patients in the community setting Mary Mc Clenaghan Advanced Specialist Head and Neck Dietitian, South London Community Head and Neck Team,
More informationNW SMS icons. Evidence-based guidelines for the nutritional management of adult oncology patients.
NW SMS icons Evidence-based guidelines for the nutritional management of adult oncology patients https://learn.extension.org/events/3026 This material is based upon work supported by the National Institute
More informationROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
Annals of Oncology 28: 1949 1956, 2017 doi:10.1093/annonc/mdx192 Published online 4 May 2017 ORIGINAL ARTICLE : a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC)
More informationMALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview
MALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ Temple 1 Cachexia:
More informationPediatric Oncology Dietitian BY BRANDON L. LEE, TOIVO PASTO, TINA VEILSON AND ALYSSA RANSANICI
Pediatric Oncology Dietitian BY BRANDON L. LEE, TOIVO PASTO, TINA VEILSON AND ALYSSA RANSANICI Part 1: What a Pediatric Oncology Dietitian is? A health care professional who has special training in pediatrics
More informationGeriatric Nutrition Assessment for Primary Care Providers
Geriatric Nutrition Assessment for Primary Care Providers July 16, 2008 NRHA Quality and Clinical Conference Esther M. Forti, PhD, RN Vicky J. Ott, MS, RD Funding Source: HRSA Bureau of Primary Health
More informationOral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis
DOI: 10.1093/jnci/djr556 Advance Access publication on February 15, 2012. The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
More informationDietetic Outcomes in Home Parenteral Nutrition
Dietetic Outcomes in Home Parenteral Nutrition Dr Alison Culkin Research Dietitian Intestinal Failure & Home Parenteral Nutrition St Mark s Hospital PENG Meeting November 2011 The Dietetic Outcomes Model
More informationSymptom Assessment in Palliative Care
Symptom Assessment in Palliative Care Maria Nabal www.arnau.scs.es Sumary SYMPTOM ASSESSMENT Is it really necessary? What for? Which symptoms? How to conduct the assessment? Is there any other area of
More informationFATIGUE: PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT. Fausto Roila Medical Oncology Division, Terni, Italy
FATIGUE: PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT Fausto Roila Medical Oncology Division, Terni, Italy CONFLICT OF INTERESTS NO CONFLICT FATIGUE: DEFINITION (ASCO, NCCN) Cancer-related fatigue
More informationBlending Perspectives and Bridging Differences: Weaving Clinical Research into Whole Person Care
Blending Perspectives and Bridging Differences: Weaving Clinical Research into Whole Person Care Dr. Cheryl Nekolaichuk Division of Palliative Care Medicine, University of Alberta Edmonton Palliative Care
More informationDignity and Nutrition for Older People
South Gloucestershire Community Health Services Dignity and Nutrition for Older People Lorraine Norris Nutrition and Dietetic Professional Lead South Gloucestershire Community Health November 9th 2011
More informationThemes. Evaluer (defini:on, diagnos:c criteria) Recherche clinique en cancérologie : quid du statut nutri:onnel? Agir Adapter 03/04/15
Recherche clinique en cancérologie : quid du statut nutri:onnel? Pierre Senesse, Laboratoire Epsylon, Ins:tut Régional du Cancer de Montpellier SIRIC Vickie Baracos, Department of Oncology, University
More informationPharmacological treatments. Jann Arends Tumor Biology Center Freiburg, Germany
Pharmacological treatments Jann Arends Tumor Biology Center Freiburg, Germany Pharmacologic treatment: Basic concept Interfere with undesired physiology Drug a specific target Major problems in cachexia
More informationPalliative Care: Expanding the Role Throughout the Patient s Journey. Dr. Robert Sauls Regional Lead for Palliative Care
Palliative Care: Expanding the Role Throughout the Patient s Journey Dr. Robert Sauls Regional Lead for Palliative Care 1 Faculty/Presenter Disclosure Faculty: Dr. Robert Sauls MD, with the Mississauga
More informationHIV Nutrition & Health Benefits
Outline HIV Nutrition & Health Benefits Jenn Messina, RD HIV/AIDS Program St. Paul s Hospital, Vancouver February 7 th, 2013 Personal intro HIV Globally Nutritional issues in HIV Asymptomatic & symptomatic
More information